Cutler Group’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-367
| Closed | -$2K | – | 1558 |
|
|
2023
Q3 | $2K | Hold |
367
| – | – | ﹤0.01% | 1253 |
|
|
2023
Q2 | $1K | Hold |
367
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q1 | $1K | Sell |
367
-366
| -50% | -$997 | ﹤0.01% | 1324 |
|
|
2022
Q4 | $2K | Hold |
733
| – | – | ﹤0.01% | 1561 |
|
|
2022
Q3 | $2K | Hold |
733
| – | – | ﹤0.01% | 1725 |
|
|
2022
Q2 | $9K | Hold |
733
| – | – | ﹤0.01% | 1401 |
|
|
2022
Q1 | $3K | Hold |
733
| – | – | ﹤0.01% | 1760 |
|
|
2021
Q4 | $5K | Hold |
733
| – | – | ﹤0.01% | 1806 |
|
|
2021
Q3 | $22K | Hold |
733
| – | – | ﹤0.01% | 1500 |
|
|
2021
Q2 | $23K | Hold |
733
| – | – | ﹤0.01% | 1498 |
|
|
2021
Q1 | $27K | Hold |
733
| – | – | ﹤0.01% | 1367 |
|
|
2020
Q4 | $34K | Hold |
733
| – | – | ﹤0.01% | 1114 |
|
|
2020
Q3 | $23K | Hold |
733
| – | – | ﹤0.01% | 1108 |
|
|
2020
Q2 | $32K | Hold |
733
| – | – | ﹤0.01% | 976 |
|
|
2020
Q1 | $24K | Hold |
733
| – | – | ﹤0.01% | 949 |
|
|
2019
Q4 | $37K | Sell |
733
-296
| -29% | -$14.9K | ﹤0.01% | 988 |
|
|
2019
Q3 | $37K | Hold |
1,029
| – | – | ﹤0.01% | 901 |
|
|
2019
Q2 | $56K | Buy |
1,029
+922
| +862% | +$50.2K | 0.01% | 874 |
|
|
2019
Q1 | $6K | Hold |
107
| – | – | ﹤0.01% | 1265 |
|
|
2018
Q4 | $6K | Sell |
107
-3,773
| -97% | -$212K | ﹤0.01% | 1328 |
|
|
2018
Q3 | $313K | Buy |
3,880
+2,680
| +223% | +$216K | 0.02% | 453 |
|
|
2018
Q2 | $105K | Buy |
1,200
+1,040
| +650% | +$91K | 0.01% | 685 |
|
|
2018
Q1 | $30K | Buy |
+160
| New | +$30K | ﹤0.01% | 1086 |
|
|
2017
Q3 | – | Sell |
-120
| Closed | -$4K | – | 2708 |
|
|
2017
Q2 | $4K | Buy |
+120
| New | +$4K | ﹤0.01% | 2452 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3026 |
|
|
2016
Q1 | – | Sell |
-39
| Closed | -$13K | – | 3019 |
|
|
2015
Q4 | $13K | Buy |
+39
| New | +$13K | ﹤0.01% | 2048 |
|